drugset / Trial / NCT00524056
A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of carisbamate treatment for the signs, symptoms, and impairment associated with Essential Tremor (ET) compared to placebo treatment. The secondary objective is to evaluate the effect of carisbamate treatment on indicators of affect and mood in patients who have ET compared to placebo treatment.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carisbamate | Small molecule | 200 mg | Oral |